Related references
Note: Only part of the references are listed.Voriconazole-Associated Cutaneous Malignancy: A Literature Review on Photocarcinogenesis in Organ Transplant Recipients
Kiyanna Williams et al.
CLINICAL INFECTIOUS DISEASES (2014)
Phenotypic Differences of Cryptococcus Molecular Types and Their Implications for Virulence in a Drosophila Model of Infection
George R. Thompson et al.
INFECTION AND IMMUNITY (2014)
Fungal Disease of the Nose and Sinuses: An Updated Overview
Christopher Chang et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2013)
Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies
Boni E. Elewski et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
A Dimorphic Fungus Causing Disseminated Infection in South Africa
Chris Kenyon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Phylogenetic Analysis Reveals a Cryptic Species Blastomyces gilchristii, sp nov within the Human Pathogenic Fungus Blastomyces dermatitidis
Elizabeth M. Brown et al.
PLOS ONE (2013)
Global Burden of Human Mycetoma: A Systematic Review and Meta-analysis
Wendy W. J. van de Sande
PLOS NEGLECTED TROPICAL DISEASES (2013)
Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension
Gopal Krishna et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Fungal disease of the nose and paranasal sinuses
George R. Thompson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers
G. Krishna et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Adiaspiromycosis Causing Respiratory Failure and a Review of Human Infections Due to Emmonsia and Chrysosporium spp.
Gregory M. Anstead et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
A Decade of Experience: Cryptococcus gattii in British Columbia
Karen H. Bartlett et al.
MYCOPATHOLOGIA (2012)
Treatment of Refractory Coccidioidomycosis With Voriconazole or Posaconazole
Michelle M. Kim et al.
CLINICAL INFECTIOUS DISEASES (2011)
Sporothrix schenckii and Sporotrichosis
Monica Bastos de Lima Barros et al.
CLINICAL MICROBIOLOGY REVIEWS (2011)
Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis
Hong Liang Tey et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Pulmonary Coccidioidomycosis
George R. Thompson
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Pulmonary Aspergillosis: Recent Advances
George R. Thompson et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
In Vitro Antifungal Susceptibilities and Amplified Fragment Length Polymorphism Genotyping of a Worldwide Collection of 350 Clinical, Veterinary, and Environmental Cryptococcus gattii Isolates
Ferry Hagen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
John R. Perfect et al.
CLINICAL INFECTIOUS DISEASES (2010)
Epidemiology of superficial fungal infections
Mahreen Ameen
CLINICS IN DERMATOLOGY (2010)
Pharmacology and clinical use of voriconazole
George R. Thompson et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Isavuconazole: A Comprehensive Review of Spectrum of Activity of a New Triazole
George R. Thompson et al.
MYCOPATHOLOGIA (2010)
Guidelines for the Management of Tinea Capitis in Children
Talia Kakourou et al.
PEDIATRIC DERMATOLOGY (2010)
Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans
George R. Thompson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers
Gopal Krishna et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
David Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Overview of Antifungal Agents
George R. Thompson et al.
CLINICS IN CHEST MEDICINE (2009)
Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment
Flavio Queiroz-Telles et al.
MEDICAL MYCOLOGY (2009)
Cladophialophora saturnica sp nov., a new opportunistic species of Chaetothyriales revealed using molecular data
H. Badali et al.
MEDICAL MYCOLOGY (2009)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
The effect of gastric acid on the absorption of posaconazole
Rupali Jain et al.
CLINICAL INFECTIOUS DISEASES (2008)
Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America
Stanley W. Chapman et al.
CLINICAL INFECTIOUS DISEASES (2008)
Treatment options for paracoccidioidomycosis and new strategies investigated
Luiz R. Travassos et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
Updates on the Epidemiology of Dermatophyte Infections
Claus Seebacher et al.
MYCOPATHOLOGIA (2008)
New and emerging treatments for fungal infections
A. C. Pasqualotto et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of Paracoccidioidomycosis
Flavio Queiroz-Telles et al.
CLINICAL INFECTIOUS DISEASES (2007)
Clinical practice guidelines for the management of sporotrichosis: 2007 update by the infectious diseases society of America
Carol A. Kauffman et al.
CLINICAL INFECTIOUS DISEASES (2007)
Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the infectious diseases society of America
L. Joseph Wheat et al.
CLINICAL INFECTIOUS DISEASES (2007)
A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement
R. Baran et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Adverse effects of voriconazole:: Analysis of the French pharmacovigilance database
Celine Eiden et al.
ANNALS OF PHARMACOTHERAPY (2007)
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
Oliver A. Cornely et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
Andrew J. Ullmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2007)
Coccidioidomycosis: A review and update
David J. DiCaudo
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Urine antigen detection of blastomycosis in pediatric patients
Kanokporn Mongkolrattanothai et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Long QTc interval and torsade de pointes caused by fluconazole
C. Phu Pharn et al.
ANNALS OF PHARMACOTHERAPY (2006)
What is the current and future status of conventional amphotericin B?
Michael Kleinberg
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions
II Raad et al.
CLINICAL INFECTIOUS DISEASES (2006)
Effect of a nutritional supplement on posaconazole pharmacokinetics following oral administration to healthy volunteers
A Sansone-Parsons et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Diagnosis and management of candida of the nipple and breast
S Wiener
JOURNAL OF MIDWIFERY & WOMENS HEALTH (2006)
In vitro activity of a new triazole BAL4815, the active component of BAL8557 (the water-soluble prodrug), against Aspergillus spp.
PA Warn et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Tropical dermatology: Fungal tropical diseases
O Lupi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Tinea nigra: Report of twelve cases in Venezuela
C Perez et al.
MYCOPATHOLOGIA (2005)
Retrospective study of onychomycosis in Italy: 1985-2000
C Romano et al.
MYCOSES (2005)
Epidemiology and outcome of zygomycosis: A review of 929 reported cases
MM Roden et al.
CLINICAL INFECTIOUS DISEASES (2005)
Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002
KW Foster et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Infections due to emerging and uncommon medically important fungal pathogens
TJ Walsh et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis
AK Gupta et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Antigen assay with the potential to aid in diagnosis of blastomycosis
M Durkin et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Mycetoma caused by Madurella mycetomatis:: a neglected infectious burden
AOA Ahmed et al.
LANCET INFECTIOUS DISEASES (2004)
Diagnosis and management of scalp ringworm
LC Fuller et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Voriconazole: A new triazole antifungal agent
LB Johnson et al.
CLINICAL INFECTIOUS DISEASES (2003)
Primary cutaneous cryptococcosis: A distinct clinical entity
S Neuville et al.
CLINICAL INFECTIOUS DISEASES (2003)
Terbinafine - A review of its use in onychomycosis in adults
MJM Darkes et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2003)
Comparison of caspofungin and amphotericin B for invasive candidiasis.
J Mora-Duarte et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Cutaneous infection by Fusarium species in healthy and Immunocompromised hosts:: Implications for diagnosis and management
M Nucci et al.
CLINICAL INFECTIOUS DISEASES (2002)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Cutaneous inoculation blastomycosis
NA Gray et al.
CLINICAL INFECTIOUS DISEASES (2002)
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi:: Report from SENTRY Antimicrobial Surveillance Program, 2000
MA Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Congestive heart failure associated with itraconazole
SR Ahmad et al.
LANCET (2001)
Paracoccidioidomycosis in Colombia:: an ecological study
D Calle et al.
EPIDEMIOLOGY AND INFECTION (2001)
Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis
AK Gupta et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)
Malassezia globosa as the causative agent of pityriasis versicolor
VC Erchiga et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592)
EK Manavathu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: A multicenter Canadian survey of 15,000 patients
AK Gupta et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)
Practice guidelines for diseases caused by Aspergillus
DA Stevens et al.
CLINICAL INFECTIOUS DISEASES (2000)
Practice guidelines for the treatment of coccidioidomycosis
JN Galgiani et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
